Document details

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy


Description

Submitted by Biblioteca Suporte PUCRS (biblioteca.suporte@pucrs.br) on 2022-05-17T14:47:21Z No. of bitstreams: 2 Change_in_Neutrophiltolymphocyte_Ratio_in_Response_to_Targeted_Therapy_for_Metastatic_Renal_Cell_Carcinoma_as_a.pdf: 2478964 bytes, checksum: 928518678dc143e8984bbff25e00ab99 (MD5) Change_in_Neutrophiltolymphocyte_Ratio_in_Response_to_Targeted_Therapy_for_Metastatic_Renal_Cell_Carcinoma_as_a.pdf: 2478964 bytes, checksum: 928518678dc143e8984bbff25e00ab99 (MD5)

Made available in DSpace on 2022-05-17T14:47:21Z (GMT). No. of bitstreams: 2 Change_in_Neutrophiltolymphocyte_Ratio_in_Response_to_Targeted_Therapy_for_Metastatic_Renal_Cell_Carcinoma_as_a.pdf: 2478964 bytes, checksum: 928518678dc143e8984bbff25e00ab99 (MD5) Change_in_Neutrophiltolymphocyte_Ratio_in_Response_to_Targeted_Therapy_for_Metastatic_Renal_Cell_Carcinoma_as_a.pdf: 2478964 bytes, checksum: 928518678dc143e8984bbff25e00ab99 (MD5) Previous issue date: 2016

Document Type Journal article
Language English
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents